The SARS-CoV-2 outbreak and pandemic that began near the end of 2019 has posed a
challenge to global health. At present, many candidate small-molecule therapeutics have …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brutally perils physical and
mental health worldwide. Unavailability of effective anti-viral drug rendering global threat of …

The SARS-CoV-2 pandemic is considered as one of the most disastrous pandemics for
human health and the world economy. RNA-dependent RNA polymerase (RdRp) is one of …

COVID-19 caused by the novel SARS-CoV-2 has been declared a pandemic by the WHO is
causing havoc across the entire world. As of May end, about 6 million people have been …

Abstract COVID‐19, caused by SARS‐CoV‐2 infection, continues to be a major public
health crisis around the globe. Development of vaccines and the first cluster of antiviral …

A consensus virtual screening protocol has been applied to ca. 2000 approved drugs to
seek inhibitors of the main protease (Mpro) of SARS-CoV-2, the virus responsible for COVID …

SARS-CoV-2 (severe acute respiratory syndrome coronavirus‐2), a member of the
coronavirus family, appeared in 2019 and has caused the largest global public health and …

Effective, safe, and pharmacokinetically suitable drugs are urgently needed to curb the
ongoing COVID-19 pandemic. The main protease or 3C-like protease (M pro or 3CL pro) of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared in 2019 and is
the causative agent of the new pandemic viral disease COVID-19. The outbreak of COVID …

The outbreak of a new coronavirus (SARS-CoV-2), which is responsible for the COVID-19
disease and is spreading rapidly around the world, urgently requires effective therapeutic …